• Subscribe
  • Log In
  • Home
  • Daily Diary
  • Asset Class
    • U.S. Equity
    • Fixed Income
    • Global Equity
    • Commodities
    • Currencies
  • Sector
    • Basic Materials
    • Consumer Discretionary
    • Consumer Staples
    • Energy
    • Financial Services
    • Healthcare
    • Industrials
    • Real Estate
    • Technology
    • Telecom Services
    • Transportation
    • Utilities
  • Latest
    • Articles
    • Video
    • Columnist Conversations
    • Best Ideas
    • Stock of the Day
  • Street Notes
  • Authors
    • Doug Kass
    • Bruce Kamich
    • Jim Cramer
    • Jim "Rev Shark" DePorre
    • Helene Meisler
    • Jonathan Heller
    • - See All -
  • Options
  • RMPIA
  • Switch Product
    • Action Alerts PLUS
    • Quant Ratings
    • Real Money
    • Real Money Pro
    • Retirement
    • Stocks Under $10
    • TheStreet
    • Top Stocks
    • Trifecta Stocks
  1. Home
  2. / Investing
  3. / Industrials

Pall Deal Wouldn't Make Sense for Thermo

There's no reason for Thermo to start a bidding war.
By JACK MOHR May 13, 2015 | 03:52 PM EDT
Stocks quotes in this article: TMO, PLL, DHR

This morning, Danaher (DHR) announced a cash deal to acquire Pall (PLL) for $127.20 per share for a value of approximately $13.8 billion. This would suggest a valuation of 21x trailing EBITDA based on Pall's consensus estimates. Additionally, Danaher plans to split into two separate entities with most of its life sciences-related businesses part of a company retaining the Danaher name and the other segments part of the other company.

While we believe the deal makes sense for Danaher, we don't think it would make sense at this valuation for Thermo Fisher Scientific (TMO), which is also reportedly interested in the Pall asset.

For one, Danaher has a cash hoard, and its current debt/EBITDA ratio is about 1.0x, which will allow it to raise less debt at a cheaper price (under 2% interest rate). TMO, on the other hand, has a 3.6x debt/EBITDA ratio vs. the company's target of 2.5x-3x. It has also been more aggressive in capital allocation so far this year ($500 million share repurchase, $300 million acquisition of Advanced Scientifics) and not necessarily preserving capital for a larger deal.

Our proprietary accretion analysis does not support a TMO acquisition at the suggested valuation. In fact, the $13.8 billion price tag implies over 1% dilution, even under our most aggressive assumptions. Thermo would first have to lever up to 4.5x pro-forma EBITDA and borrow $8.3 billion at relatively high rates (we assume 3.2%), which would leave about $5.5 billion of equity to raise (or 42 million shares at the current price). We also assume Thermo is able to work its tax rate magic to bring the blended tax rate to the company's current corporate tax rate of 14%-15%. The result of all this work suggests Thermo's pro-forma earnings per share would come in at roughly $8.00/share, $0.10 below current consensus estimates for $8.10/share.

Since Danaher, alternatively, is likely to achieve high- single-digit accretion from the PLL acquisition, we see no reason for Thermo to instigate a bidding war as it is at a severe disadvantage. We believe other, more reasonably valued opportunities, will present themselves in the space and look forward to Thermo paying down some debt in the meantime to build capacity.

Jim Cramer's charitable trust Action Alerts PLUS owns TMO. Read his thoughts on the company's recent earnings here.

Get an email alert each time I write an article for Real Money. Click the "+Follow" next to my byline to this article.

Action Alerts PLUS, which Mohr co-manages as a charitable trust, is long TMO.

TAGS: Investing | U.S. Equity | Industrials

More from Industrials

Cleveland-Cliffs Looks Ready to Resume Its Uptrend

Bruce Kamich
Apr 22, 2021 1:46 PM EDT

Here's how to play it.

Regal-Beloit Looks Promising: How to Play It

Bruce Kamich
Apr 22, 2021 12:55 PM EDT

These under-the-radar shares have more than doubled over the past 12 months.

PPG Has Come Roaring Back to New Highs

Bruce Kamich
Apr 22, 2021 9:44 AM EDT

A real company with real earnings and real growth.

MicroVision's Charts Are Pointed Lower

Bruce Kamich
Apr 20, 2021 2:10 PM EDT

Avoid the long side of MVIS.

GE Isn't a Value Play and Has No Earnings Momentum - Buy Some Puts

Jim Collins
Apr 16, 2021 12:11 PM EDT

The company is in a secular downtrend fundamentally, but the stock has risen with the market in this wild ride over the past 12 months.

Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation. If you have questions, please contact us here.

Email

CANCEL
SUBMIT

Email sent

Thank you, your email to has been sent successfully.

DONE

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

DONE

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight

Already a Subscriber? Login

Columnist Conversation

  • 07:35 AM EDT BOB LANG

    Join Me for a Special Earth Day Webinar, Talking Volatility and VIX

    After the close Thursday join me for a free webina...
  • 04:17 PM EDT REAL MONEY

    Wednesday on Real Money Pro

    Get-rich quick schemes offer little more than pipe...
  • 11:09 AM EDT GARY BERMAN

    S&P Futures

    FIBOCALL: The S&P futures was off 1.5 %... ...
  • See More

COLUMNIST TWEETS

  • A Twitter List by realmoney
About Privacy Terms of Use

© 1996-2021 TheStreet, Inc., 225 Liberty Street, 27th Floor, New York, NY 10281

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.

Compare Brokers

Please Join or Log In to manage and receive alerts.

Follow Real Money's Wall Street Pros to receive real-time investing alerts

Already a Subscriber? Login